Pelc, Z.; Skórzewska, M.; Kurylcio, M.; Nowikiewicz, T.; Mlak, R.; Sędłak, K.; Gęca, K.; Rawicz-Pruszyński, K.; Zegarski, W.; Polkowski, W.P.;
et al. A Propensity Score Matched Analysis of Superparamagnetic Iron Oxide versus Radioisotope Sentinel Node Biopsy in Breast Cancer Patients after Neoadjuvant Chemotherapy. Cancers 2022, 14, 676.
https://doi.org/10.3390/cancers14030676
AMA Style
Pelc Z, Skórzewska M, Kurylcio M, Nowikiewicz T, Mlak R, Sędłak K, Gęca K, Rawicz-Pruszyński K, Zegarski W, Polkowski WP,
et al. A Propensity Score Matched Analysis of Superparamagnetic Iron Oxide versus Radioisotope Sentinel Node Biopsy in Breast Cancer Patients after Neoadjuvant Chemotherapy. Cancers. 2022; 14(3):676.
https://doi.org/10.3390/cancers14030676
Chicago/Turabian Style
Pelc, Zuzanna, Magdalena Skórzewska, Maria Kurylcio, Tomasz Nowikiewicz, Radosław Mlak, Katarzyna Sędłak, Katarzyna Gęca, Karol Rawicz-Pruszyński, Wojciech Zegarski, Wojciech P. Polkowski,
and et al. 2022. "A Propensity Score Matched Analysis of Superparamagnetic Iron Oxide versus Radioisotope Sentinel Node Biopsy in Breast Cancer Patients after Neoadjuvant Chemotherapy" Cancers 14, no. 3: 676.
https://doi.org/10.3390/cancers14030676
APA Style
Pelc, Z., Skórzewska, M., Kurylcio, M., Nowikiewicz, T., Mlak, R., Sędłak, K., Gęca, K., Rawicz-Pruszyński, K., Zegarski, W., Polkowski, W. P., & Kurylcio, A.
(2022). A Propensity Score Matched Analysis of Superparamagnetic Iron Oxide versus Radioisotope Sentinel Node Biopsy in Breast Cancer Patients after Neoadjuvant Chemotherapy. Cancers, 14(3), 676.
https://doi.org/10.3390/cancers14030676